Related Experiment Video
Updated: Jun 2, 2026
10:58
Methods to Study Lipid Alterations in Neutrophils and the Subsequent Formation of Neutrophil Extracellular Traps
Published on: March 29, 2017
Statins: a role in infected critically ill patients?
1Pulmonary and Critical Care Medicine, University of Virginia, Box 800793, Charlottesville, VA 22908, USA. truwit@virginia.edu.
Critical Care (London, England)
|April 15, 2011
Summary
Statins did not prevent organ dysfunction in critically ill patients with sepsis. This retrospective study adds to the debate, highlighting the need for randomized controlled trials to clarify statin use in sepsis management.
Area of Science:
- Critical Care Medicine
- Pharmacology
- Clinical Trials
Background:
- The role of statins in sepsis management remains controversial.
- Existing research is largely retrospective, limiting definitive conclusions.
Purpose of the Study:
- To investigate the effect of statins on organ dysfunction progression in critically ill patients with sepsis.
- To contribute evidence to the ongoing debate on statin therapy in sepsis.
Main Methods:
- Retrospective analysis of patient data.
- Examination of statin use and its association with organ dysfunction in sepsis.
Main Results:
- Statins failed to prevent the progression to organ dysfunction in critically ill patients with sepsis.
- The study's retrospective nature limits causal inference.
Conclusions:
- Current evidence from retrospective studies is insufficient to resolve the controversy surrounding statins in sepsis.
- There is a critical need for well-designed, randomized controlled trials to establish the efficacy and safety of statins in sepsis.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:14Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
01:29Endocarditis IV: Nursing Management
Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
01:26Angina IV: Management
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...